Published in Arch Pharm Res on May 27, 2009
Maintenance of the viral genome may be the Achilles' tendon for virus-associated cancer. Arch Pharm Res (2009) 0.75
Acute myeloid leukemia associated with FGFR1 abnormalities. Int J Hematol (2013) 2.12
Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol (2006) 1.62
Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother (2005) 1.55
Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement. Ann Hematol (2011) 1.46
A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology (2004) 1.15
Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther (2004) 1.14
Maternal age-specific rates of fetal chromosomal abnormalities at 16-20 weeks' gestation in Korean pregnant women >or=35 years of age. Fetal Diagn Ther (2010) 1.11
Comparison of allele specific oligonucleotide-polymerase chain reaction and direct sequencing for high throughput screening of ABL kinase domain mutations in chronic myeloid leukemia resistant to imatinib. Haematologica (2006) 1.07
LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells. BMC Cancer (2010) 1.07
Variant of ETV6/ABL1 gene is associated with leukemia phenotype. Acta Haematol (2012) 1.06
Regulation of TNF-alpha-mediated hyperplasia through TNF receptors, TRAFs, and NF-kappaB in synoviocytes obtained from patients with rheumatoid arthritis. Immunol Lett (2002) 1.04
[Serum free light chains for diagnosis and follow-up of multiple myeloma]. Korean J Lab Med (2008) 1.04
Identification of a stroma-mediated Wnt/beta-catenin signal promoting self-renewal of hematopoietic stem cells in the stem cell niche. Stem Cells (2009) 1.00
JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia. Korean J Hematol (2010) 0.98
Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol (2013) 0.97
Bortezomib in combination with conventional chemotherapeutic agents for multiple myeloma compared with bortezomib alone. Jpn J Clin Oncol (2007) 0.96
Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization. FASEB J (2010) 0.96
Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001. J Korean Med Sci (2004) 0.95
Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP. World J Gastroenterol (2013) 0.94
X-linked spondyloepiphyseal dysplasia tarda: Identification of a TRAPPC2 mutation in a Korean pedigree. Ann Lab Med (2012) 0.94
Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1. J Gen Virol (2012) 0.92
Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential. Stem Cells Dev (2009) 0.90
Molecular analysis of the PAX6 gene for congenital aniridia in the Korean population: identification of four novel mutations. Mol Vis (2012) 0.90
Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants. Ann Clin Lab Sci (2010) 0.89
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). PLoS One (2008) 0.89
Isolation and characterization of chorionic mesenchymal stromal cells from human full term placenta. J Korean Med Sci (2012) 0.88
The characteristics and clinical outcome of adult patients with aplastic anemia and abnormal cytogenetics at diagnosis. Genes Chromosomes Cancer (2010) 0.88
Impact of genetic abnormalities on the prognoses and clinical parameters of patients with multiple myeloma. Ann Lab Med (2013) 0.87
Cytogenetic characteristics and prognosis analysis in 231 myelodysplastic syndrome patients from a single institution. Leuk Res (2010) 0.87
Viral microRNA profile in Epstein-Barr virus-associated peripheral T cell lymphoma. Br J Haematol (2008) 0.87
The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines. Exp Mol Med (2011) 0.86
Utility of a multiplex reverse transcriptase-polymerase chain reaction assay (HemaVision) in the evaluation of genetic abnormalities in Korean children with acute leukemia: a single institution study. Korean J Pediatr (2013) 0.86
[Usefulness of real-time semi-quantitative PCR, JAK2 MutaScreen kit for JAK2 V617F screening]. Korean J Lab Med (2009) 0.86
Establishment and characterization of an in vivo model for Epstein-Barr virus positive gastric carcinoma. J Med Virol (2007) 0.86
Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis. Arthritis Res Ther (2014) 0.86
Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course. J Korean Med Sci (2005) 0.85
Early apoptosis in CD34+ cells as a potential heterogeneity in quality of cryopreserved umbilical cord blood. Br J Haematol (2006) 0.85
Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma. Mol Cells (2011) 0.85
Novel method to dissociate platelet clumps in EDTA-dependent pseudothrombocytopenia based on the pathophysiological mechanism. Clin Chem Lab Med (2012) 0.85
Discordant lymphocyte-depleted classical Hodgkin's and peripheral T-cell lymphoma arising in a patient 11 years after diagnosis of multicentric Castleman's disease. Int J Hematol (2013) 0.84
Sustained response to low-dose imatinib mesylate in a patient with chronic myelomonocytic leukemia with t(5;12)(q33;p13). Acta Haematol (2008) 0.84
Prenatal diagnosis of autosomal recessive polycystic kidney disease by molecular genetic analysis. J Obstet Gynaecol Res (2011) 0.84
Centrosome abnormalities in non-small cell lung cancer: correlations with DNA aneuploidy and expression of cell cycle regulatory proteins. Pathol Res Pract (2007) 0.83
CD56 antigen expression and hemophagocytosis of leukemic cells in acute myeloid leukemia with t(16;21)(p11;q22). Int J Hematol (2010) 0.83
The long-term clinical implications of clonal chromosomal abnormalities in newly diagnosed chronic phase chronic myeloid leukemia patients treated with imatinib mesylate. Cancer Genet (2012) 0.83
Expression of functional markers in acute lymphoblastic leukemia. Leuk Res (2003) 0.83
B lymphoblastic leukemia with ETV6 amplification. Cancer Genet Cytogenet (2010) 0.83
CpG-oligodeoxynucleotide protects immune cells from gamma-irradiation-induced cell death. Mol Immunol (2005) 0.82
Pseudomembranous colitis following bortezomib therapy in a myeloma patient. Acta Haematol (2007) 0.82
Analysis of immunoglobulin and T cell receptor gene rearrangement in the bone marrow of lymphoid neoplasia using BIOMED-2 multiplex polymerase chain reaction. Int J Med Sci (2013) 0.82
Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil. Arch Pharm Res (2011) 0.82
Quantitative analysis of urine sediment using newly designed centrifuge tubes. Ann Clin Lab Sci (2002) 0.81
Prenatal diagnosis of congenital lipoid adrenal hyperplasia (CLAH) by molecular genetic testing in Korean siblings. Yonsei Med J (2011) 0.81
A novel nonsense mutation of the SLC4A11 gene in a Korean patient with autosomal recessive congenital hereditary endothelial dystrophy. Cornea (2013) 0.81
Membrane binding properties of EBV gp110 C-terminal domain; evidences for structural transition in the membrane environment. Virology (2008) 0.81
A new compound heterozygous mutation in the CYP17A1 gene in a female with 17α-hydroxylase/17,20-lyase deficiency. Gynecol Endocrinol (2013) 0.81
Validation of Western common recurrent chromosomal aberrations in Korean chronic lymphocytic leukaemia patients with very low incidence. Hematol Oncol (2013) 0.80
[Diamond-Blackfan anemia confirmed by RPS19 gene mutation analysis: a case study and literature review of Korean patients]. Korean J Lab Med (2010) 0.80
Plasma eosinophil cationic protein, interleukin-5, and ECP/Eo count ratio in patients with various eosinophilic diseases. Ann Clin Lab Sci (2006) 0.80
TGFBR2 gene polymorphism is associated with ossification of the posterior longitudinal ligament. J Clin Neurosci (2012) 0.80
Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma. Jpn J Clin Oncol (2009) 0.80
[Molecular analysis of two cases of severe congenital neutropenia]. Korean J Lab Med (2010) 0.80
Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia. Ann Clin Lab Sci (2004) 0.80
Evaluation of NK cell function by flowcytometric measurement and impedance based assay using real-time cell electronic sensing system. Biomed Res Int (2013) 0.79
Altered immune cell proportions in the radiodermatitis induced hairless mice-1 (HR-1). J Radiat Res (2006) 0.79
Intracellular IL-4, IL-10, and IFN-gamma levels of leukemic cells and bone marrow T cells in acute leukemia. Ann Clin Lab Sci (2006) 0.79
Genotype-phenotype correlation of a 5q22.3 deletion associated with craniofacial and limb defects. Gene (2011) 0.79
Mycobacterial infections in coal workers' pneumoconiosis patients in South Korea. Scand J Infect Dis (2009) 0.79
Arsenic trioxide (As2O3) sensitivity of carcinoma cell lines and cancer cells from patients with carcinomatosis peritonei. Ann Clin Lab Sci (2004) 0.79
Feasibility of a microarray-based point-of-care CYP2C19 genotyping test for predicting clopidogrel on-treatment platelet reactivity. Biomed Res Int (2013) 0.78
Molecular analysis of Korean patients with oculocutaneous albinism. Jpn J Ophthalmol (2011) 0.78
Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen. Ann Clin Lab Sci (2003) 0.78
Biogenesis of Epstein-Barr virus microRNAs. Mol Cell Biochem (2012) 0.78
Three-way complex translocations in infant acute myeloid leukemia with t(7;12)(q36;p13): the incidence and correlation of a HLXB9 overexpression. Cancer Genet Cytogenet (2009) 0.78
The affecting factors of breast anthropometry in Korean women. Breastfeed Med (2013) 0.78
[A case of therapy-related acute myeloid leukemia associated with inv(16)]. Korean J Lab Med (2007) 0.78
Acute interstitial nephritis due to nicergoline (Sermion). Nephron (2002) 0.78
Induction of efficient differentiation and survival of porcine neonatal pancreatic cell clusters using an EBV-based plasmid expressing HGF. J Biochem (2008) 0.78
[Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis]. Korean J Lab Med (2008) 0.78
Effect of tandem rare codon substitution and vector-host combinations on the expression of the EBV gp110 C-terminal domain in Escherichia coli. Protein Expr Purif (2002) 0.77
Prolonged gene expression in primary porcine pancreatic cells using an Epstein-Barr virus-based episomal vector. Biochem Biophys Res Commun (2003) 0.77
Significance of cerebrospinal fluid sIL-2R level as a marker of CNS involvement in acute lymphoblastic leukemia. Ann Clin Lab Sci (2005) 0.77
Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clin Chem Lab Med (2015) 0.77
Monokine levels in cancer and infection. Ann Clin Lab Sci (2003) 0.77
Establishment and characterization of gastric carcinoma cell clones expressing LMP2A of Epstein-Barr virus. Int J Mol Med (2010) 0.77
The analytical performance evaluation of Freelite™ Human Kappa Free and Human Lambda Free on the SPAPLUS™ immunoturbidimetric analyzer. J Clin Lab Anal (2014) 0.77
Rapid fecal cytokeratin-19 test and fecal occult blood test in screening for gastrointestinal diseases. Ann Clin Lab Sci (2006) 0.77
G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia. Ann Clin Lab Sci (2008) 0.77
Two cases of concurrent development of essential thrombocythemia with chronic lymphocytic leukemia, one related to clonal B-cell lymphocytosis, tested by array comparative genomic hybridization. Int J Hematol (2014) 0.77
Improved gene expression pattern using Epstein-Barr virus (EBV)-based plasmid and cationic emulsion. Biomaterials (2005) 0.76
Korean patients with chronic lymphocytic leukemia show the similar types of chromosomal aberrations as those in Europe and North America. Leuk Res (2005) 0.76
Acute myeloid leukemia with MYC amplification in the homogeneous staining regions and double minutes. Cancer Genet Cytogenet (2009) 0.75
Correction of pseudoreticulocytosis in leukocytosis samples using the Sysmex XE-2100 analyzer depends on the type and number of white blood cells. Ann Lab Med (2012) 0.75
Evaluation of enzymatic BM Test HbA1c on the JCA-BM6010/C and comparison with Bio-Rad Variant II Turbo, Tosoh HLC 723 G8, and AutoLab immunoturbidimetry assay. Clin Chem Lab Med (2013) 0.75
A comparison of INNOVANCE® PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention. J Clin Lab Anal (2012) 0.75
Repeated gene transfection impairs the engraftment of transplanted porcine neonatal pancreatic cells. Diabetes Metab J (2011) 0.75
Spectrin Tunis (Sp alpha (I/78)) in a Korean family with hereditary elliptocytosis. Ann Lab Med (2013) 0.75
Reply to the letter by Yang et al. RE: acute myeloid leukemia associated with FGFR1 abnormalities. Int J Hematol (2013) 0.75
Prevalence of p16 methylation and prognostic factors in plasma cell myeloma at a single institution in Korea. Ann Lab Med (2012) 0.75
Determination of acute leukemia lineage with new morphologic parameters available in the complete blood cell count. Ann Clin Lab Sci (2014) 0.75